Intelligent Bio Solutions Inc. (INBS)
$1.48-1.99%Close
SELLCRISIS · day 27
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $955,711
- Beta
- 4.30
- P/E (TTM)
- -0.16
- Short % float
- 9.14%
- Days to cover
- 1.4
- SI change
- -51.2%
- 1W
- -6.33%
- 1M
- -28.50%
- vs SPY 1W
- -6.19%
- vs SPY 1M
- -31.01%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 36
- GARP
- 3
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-102.2%
REV YoY-
ROE-70.9%
EPS YoY-
ROA-104.1%
GROSS28
OP-305
NET-295
[VALUATION]
P/E TTM-0.16
P/E FWD-
SECTOR PE20.34
INDUSTRY PE22.66
P/B0.78
P/FCF-
EV/EBITDA-0.24
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E33.01
ALTMAN Z-
CURR RATIO1.44
ND/EBITDA-
BETA4.30
NET INCOME (TTM) < 0
Company news
FAQ
- What is LOPJLB’s current signal on INBS?
- LOPJLB’s latest quantitative signal on Intelligent Bio Solutions Inc. (INBS) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is INBS in?
- Intelligent Bio Solutions Inc. (INBS) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Intelligent Bio Solutions Inc. (INBS) do?
- Intelligent Bio Solutions Inc. operates as a life sciences firm focused on developing non-invasive, real-time monitoring and diagnostic solutions for both patients and their primary healthcare providers. A notable product in its portfolio is the Saliva Glucose Biosensor, an organic thin-film transistor designed to precisely measure glucose levels in saliva for effective diabetes management. Bey…